The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Duncan Barbara Gayle since year 2005.
The trader's CIK number is 1353128.
At the time of the last reporting, Duncan Barbara Gayle was the Chief Financial Officer of Jounce Therapeutics, Inc. .
(stock ticker symbol JNCE).
See this page for all insider trading activities at Jounce Therapeutics, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-03-15 | JNCE | Jounce Therapeutics, Inc. | Option Ex | 2,000 | 4.21 | 8,420 |
| 2018-03-15 | JNCE | Jounce Therapeutics, Inc. | Sale | 2,000 | 28.11 | 56,220 |
| 2018-01-26 | JNCE | Jounce Therapeutics, Inc. | Option Ex | 4,000 | 4.21 | 16,840 |
| 2018-01-26 | JNCE | Jounce Therapeutics, Inc. | Sale | 4,000 | 25.00 | 100,000 |
| 2017-10-17 | GNMX | Aevi Genomic Medicine, Inc. | Buy | 59,524 | 1.26 | 75,000 |
| 2016-10-03 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 147 | 163.20 | 23,990 |
| 2016-07-05 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 146 | 145.11 | 21,185 |
| 2016-04-04 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 144 | 130.76 | 18,829 |
| 2016-01-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2016-01-04 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 468 | 145.90 | 68,283 |
| 2015-10-02 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 54 | 159.04 | 8,588 |
| 2015-10-01 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,000 | 163.39 | 163,390 |
| 2015-10-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 2,298 | 4.33 | 9,957 |
| 2015-07-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2015-07-02 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 53 | 237.76 | 12,601 |
| 2015-07-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,000 | 8.67 | 8,667 |
| 2015-07-01 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,000 | 242.10 | 242,100 |
| 2015-04-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2015-04-02 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 39 | 277.70 | 10,830 |
| 2015-03-27 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,000 | 288.94 | 288,937 |
| 2015-01-05 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 141 | 176.49 | 24,884 |
| 2015-01-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2015-01-02 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,000 | 31.90 | 31,900 |
| 2015-01-02 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,000 | 156.40 | 156,400 |
| 2014-10-01 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,000 | 233.90 | 233,897 |
| 2014-10-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 2,299 | 15.95 | 36,669 |
| 2014-07-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2014-04-14 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,154 | 21.50 | 24,811 |
| 2014-04-14 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,154 | 279.00 | 321,966 |
| 2014-04-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2014-01-15 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 5,625 | 31.90 | 179,437 |
| 2014-01-15 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 5,625 | 263.12 | 1,480,038 |
| 2014-01-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2013-10-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2013-07-08 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 25,000 | 45.39 | 1,134,850 |
| 2013-07-08 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 25,000 | 9.82 | 245,549 |
| 2013-07-01 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,298 | .00 | 0 |
| 2013-06-19 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 50,575 | 9.24 | 467,565 |
| 2013-06-19 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 50,575 | 34.50 | 1,744,837 |
| 2013-05-23 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 110 | 34.54 | 3,799 |
| 2013-05-24 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 1,200 | 8.67 | 10,400 |
| 2013-05-23 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 110 | 8.67 | 953 |
| 2013-05-28 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 4,915 | 34.50 | 169,567 |
| 2013-05-28 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 4,915 | 8.67 | 42,598 |
| 2013-05-24 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 1,200 | 34.50 | 41,400 |
| 2013-05-20 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 28,200 | 15.08 | 425,340 |
| 2013-05-20 | ICPT | Intercept Pharmaceuticals, Inc. | Sale | 28,200 | 34.50 | 972,900 |
| 2013-04-09 | ICPT | Intercept Pharmaceuticals, Inc. | Option Ex | 6,490 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Duncan Barbara Gayle (Chief Financial Officer of Jounce Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.